title: Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy.
authors.affiliation: a Radiation Oncology Unit, Department of Oncology and Advanced Technology , Arcispedale Santa Maria Nuova - Istituto Di Ricovero E Cura a Carattere Scientifico , Reggio Emilia , Italy ;
authors.forename: Patrizia
authors.initials: P
authors.lastname: Ciammella
authors.affiliation: b Radiation Oncology , University of Torino , Torino , Italy ;
authors.forename: Andrea Riccardo
authors.initials: AR
authors.lastname: Filippi
authors.affiliation: c Radiotherapy Unit , Azienda Ospedaliera Universitaria Careggi, University of Florence , Firenze , Italy ;
authors.forename: Gabriele
authors.initials: G
authors.lastname: Simontacchi
authors.affiliation: d Radiation Oncology Depeartment , University and Spedali Civili Hospital , Brescia , Italy ;
authors.forename: Michela
authors.initials: M
authors.lastname: Buglione
authors.affiliation: e Department of Radiation Oncology , Centro Di Riferimento Oncologico (CRO), National Cancer Institute , Aviano , Italy ;
authors.forename: Carlo
authors.initials: C
authors.lastname: Furlan
authors.affiliation: f Division of Medical Oncology , Centro Di Riferimento Oncologico (CRO), National Cancer Institute , Aviano , Italy ;
authors.forename: Michele
authors.initials: M
authors.lastname: Spina
authors.affiliation: g Division of Hematology , Spedali Civili Hospital , Brescia , Italy ;
authors.forename: Alessandra
authors.initials: A
authors.lastname: Tucci
authors.affiliation: h Hematology Unit , Azienda Ospedaliera Universitaria Careggi, University of Florence , Firenze , Italy ;
authors.forename: Luigi
authors.initials: L
authors.lastname: Rigacci
authors.affiliation: a Radiation Oncology Unit, Department of Oncology and Advanced Technology , Arcispedale Santa Maria Nuova - Istituto Di Ricovero E Cura a Carattere Scientifico , Reggio Emilia , Italy ;
authors.forename: Cinzia
authors.initials: C
authors.lastname: Iotti
authors.affiliation: i Hematology Unit , Azienda Ospedaliero Universitaria Città Della Salute E Della Scienza Di Torino , Torino , Italy ;
authors.forename: Umberto
authors.initials: U
authors.lastname: Vitolo
authors.affiliation: j Department of Oncology , University of Torino , Torino , Italy ;
authors.forename: Umberto
authors.initials: U
authors.lastname: Ricardi
authors.affiliation: k Hematology Unit, Department of Oncology and Advanced Technology , Arcispedale Santa Maria Nuova- Istituto Di Ricovero E Cura a Carattere Scientifico , Reggio Emilia , Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Merli
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D059248:Chemoradiotherapy; D005260:Female; D015577:Geriatric Assessment; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D012189:Retrospective Studies; D000069283:Rituximab / Q000008:administration & dosage*; D016019:Survival Analysis
chemical_list: D000069283:Rituximab